bupropion associated_with smoking abstinence
Evidence from:
primary |
all sources
Evidence (1 sources)
Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation.
(2008)
PMID:18593715
cited
There was a 32.0% abstinence rate in the bupropion group compared with 21.5% in the placebo group (treatment OR = 1.76).
confidence: 0.96